Prevalence and burden of general medical conditions among adults with bipolar I disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

Journal of Clinical Psychiatry

Volumn 70, Issue 10, 2009, Pages 1407-1415

  Perron, Brian E ^a,b   Howard, Matthew O ^c   Nienhuis, Jenna K ^a   Bauer, Mark S ^d   Woodward, Amanda Toler ^e   Kilbourne, Amy M ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DEFICIENCY; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; RISK FACTOR; SHORT FORM 12;

ADOLESCENT; ADULT; ALCOHOL-RELATED DISORDERS; BIPOLAR DISORDER; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DISABILITY EVALUATION; EPIDEMIOLOGY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; UNITED STATES;

EID: 72849148346     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04586yel     Document Type: Article

References (54)

1. Glahn DC, Bearden CE, Bowden CL, et al. Reduced educational attainment in bipolar disorder. J Affect Disord. 2006;92(2-3):309-312. PubMed doi:10.1016/j.jad.2006.01.025
2. Oswald P, Souery D, Kasper S, et al. Current issues in bipolar disorder: a critical review. Eur Neuropsychopharmacol. 2007;17(11):687-695. PubMed doi:10.1016/j.euroneuro.2007.03.006 (Pubitemid 47419293)
3. McDermott BE, Quanbeck CD, Frye MA. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest. Bipolar Disord. 2007;9(5):536-540. PubMed doi:10.1111/j.1399-5618.2007.00346.x
4. Frye MA, Calabrese JR, Reed ML, et al. Use of health care services among persons who screen positive for bipolar disorder. Psychiatr Serv. 2005;56(12):1529-1533. PubMed doi:10.1176/appi.ps.56.12.1529
5. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6(5):368-373. PubMed doi:10.1111/j.1399-5618.2004.00138.x (Pubitemid 39345287)
6. Jones DR, Macias C, Barreira PJ, et al. Prevalence, severity, and co-occurrence of chronic physicalhealth problems of persons with serious mental illness. Psychiatr Serv. 2004;55(11):1250-1257. PubMed doi:10.1176/appi.ps.55. 11.1250 (Pubitemid 39441587)
7. Soreca I, Fagiolini A, Frank E, et al. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res. 2008;42(11):956-961. PubMed doi:10.1016/j.jpsychires.2007.10.009
8. Bauer MS, Kirk GF, Gavin C, et al. Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study. J Affect Disord. 2001;65(3):231-241. PubMed doi:10.1016/S0165-0327(00)00247-0
9. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med. 2006;68(5):684-691. PubMed doi:10.1097/01.psy.0000237316.09601.88
10. Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002;70(1):19-26. PubMed doi:10.1016/S0165-0327(01)00456-6 (Pubitemid 34756609)
11. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192(6):421-427. PubMed doi:10.1097/01.nmd.0000130135.78017.96 (Pubitemid 38746100)
12. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Arch Intern Med. 2005;165(22):2631-2638. PubMed doi:10.1001/archinte.165.22.2631
13. Goldberg RW, Kreyenbuhl JA, Medoff DR, et al. Quality of diabetes care among adults with serious mental illness. Psychiatr Serv. 2007;58(4):536-543. PubMed doi:10.1176/appi.ps.58.4.536
14. Matthews AM, Huckans MS, Blackwell AD, et al. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord. 2008;10(2):266-270. PubMed doi:10.1111/j.1399-5618. 2007.00472.x
15. Chengappa KR, Levine J, Gershon S, et al. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord. 2000;2(3):191-195. PubMed doi:10.1034/j.1399-5618.2000.020306.x
16. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. PubMed doi:10.1001/archpsyc.61.8.807
17. Arnold LM, Witzeman KA, Swank ML, et al. Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J Affect Disord. 2000;57(1-3):235-239. PubMed doi:10.1016/S0165-0327(99)00042-7
18. Fenn HH, Bauer MS, Altshuler L, et al. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord. 2005;86(1):47-60. PubMed doi:10.1016/j.jad.2004.12.006
19. Beyer J, Kuchibhatla M, Gersing K, et al. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology. 2005;30(2):401-404. PubMed doi:10.1038/sj.npp.1300608 (Pubitemid 40129491)
20. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med. 2005;67(1):1-8. PubMed doi:10.1097/01.psy.0000151489.36347.18
21. Kilbourne AM, Rofey DL, McCarthy JF, et al. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord. 2007;9(5):443-452. PubMed doi:10.1111/j.1399-5618.2007.00386.x
22. Kilbourne AM, McCarthy JF, Welsh D, et al. Recognition of co-occurring medical conditions among patients with serious mental illness. J Nerv Ment Dis. 2006;194(8):598-602. PubMed doi:10.1097/01.nmd.0000230637.21821.ec (Pubitemid 44243877)
23. Salvatore P, Ghidini S, Zita G, et al. Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord. 2008;10(2):256-265. PubMed doi:10.1111/j.1399-5618.2007.00505.x (Pubitemid 351637689)
24. Perese EF, Perese K. Health problems of women with severe mental illness. J Am Acad Nurse Pract. 2003;15(5):212-219. PubMed doi:10.1111/j.1745-7599.2003. tb00361.x
25. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160(1):112-117. PubMed doi:10.1176/appi.ajp.160.1.112 (Pubitemid 36042434)
26. Kilbourne AM, Post EP, Bauer MS, et al. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. J Affect Disord. 2007;102(1-3):145-151. PubMed doi:10.1016/j.jad.2007.01.006
27. Bizzarri JV, Sbrana A, Rucci P, et al. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity. Bipolar Disord. 2007;9(3):213-220. PubMed doi:10.1111/j.1399-5618.2007.00383.x (Pubitemid 46547114)
28. Healey C, Peters S, Kinderman P, et al.. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: a qualitative study. J Affect Disord, 2009;113(1-2):118-126. PubMed doi:10.1016/j.jad.2008.05. 010
29. Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005;3(1):13-21. PubMed
30. Strakowski SM, DelBello MP, Fleck DE, et al. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry. 2000;48(6):477-485. PubMed doi:10.1016/S0006-3223(00)00900-8
31. Kupfer D. The increasing medical burden in bipolar disorder. JAMA. 2005;293(20):2528-2530. PubMed doi:10.1001/jama.293.20.2528 (Pubitemid 40705735)
32. Thompson WK, Kupfer DJ, Fagiolini A, et al. Prevalence and clinical correlates of medical comorbidities in patients with bipolar i disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry. 2006;67(5):783-788. PubMed (Pubitemid 43946185)
33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR. Fourth Edition. Washington, DC: American Psychiatric Association; 2000.
34. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord. 2008;10(1):67-78. PubMed
35. Grant BF, Harford TC, Dawson DA, et al. Source and Accuracy Statement for Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
36. Grant BF, Harford TC, Dawson DA, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39:37-44. PubMed doi:10.1016/0376-8716(95)01134-K
37. Hasin D, Carpenter KM, McCloud S, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44:133-141. PubMed doi:10.1016/S0376-8716(97)01332-X (Pubitemid 27129506)
38. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7-16. PubMed doi:10.1016/S0376-8716(03)00070-X
39. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360-363. PubMed
40. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. PubMed doi:10.1097/00005650-199603000-00003 (Pubitemid 126433231)
41. Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61(7):669-680. PubMed doi:10.1001/archpsyc.61.7.669
42. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73-82. PubMed doi:10.1017/S0033291703001107
43. Vojta C, Kinosian B, Glick H, et al. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry. 2001;42(3):190-195. PubMed doi:10.1053/comp.2001.23143 (Pubitemid 32410921)
44. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry. 2003;54(3):216-226. PubMed doi:10.1016/S0006-3223(03)00273-7
45. Frank E, Swartz HA, Kupfer DJ. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry. 2000;48(6):593-604. PubMed doi:10.1016/S0006-3223(00)00969-0 (Pubitemid 30702483)
46. Teh CF, Kilbourne AM, McCarthy JF, et al. Gender differences in health-related quality of life for veterans with serious mental illness. Psychiatr Serv. 2008;59(6):663-669. PubMed doi:10.1176/appi.ps.59.6.663
47. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;64(5):543-552. PubMed doi:10.1001/archpsyc.64.5.543 (Pubitemid 46718287)
48. Dickey B, Normand SL, Weiss RD, et al. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002;53(7):861-867. PubMed doi:10.1176/appi.ps.53.7.861 (Pubitemid 34742769)
49. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338(21):1516-1520. PubMed doi:10.1056/NEJM199805213382106
50. Drake RE, Mueser KT, Brunette MF. Management of persons with co-occurring severe mental illness and substance use disorder: program implications. World Psychiatry. 2007;6(3):131-136. PubMed
51. Green AI, Drake RE, Brunette MF, et al. Schizophrenia and co-occurring substance use disorder. Am J Psychiatry. 2007;164(3):402-408. PubMed doi:10.1176/appi.ajp.164.3.402
52. Jackson CT, Covell NH, Drake RE, et al. Relationship between diabetes and mortality among persons with co-occurring psychotic and substance use disorders. Psychiatr Serv. 2007;58(2):270-272. PubMed doi:10.1176/appi.ps.58.2. 270
53. Kilbourne AM, Cornelius JR, Han X, et al. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry. 2005;13(3):250-254. PubMed (Pubitemid 41031094)
54. Citrome LL, Holt RI, Zachry WM, et al. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother. 2007;41(10):1593-1603. PubMed doi:10.1345/aph.1K141